The effects of whole body vibration therapy on muscle and bone health in adolescents with motor disability.

Prof Paul Hofman0 sites40 target enrollmentFebruary 4, 2015

Overview

No summary available.

Registry

who.int

Start Date

February 4, 2015

End Date

September 13, 2018

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

Prof Paul Hofman

•adolescents with heterogeneous motor disability that is not cerebral palsy ( GMFCS II\-IV) aged between 10\-20 years. This would include patients with: mild to moderate spina bifida, genetic/disease motor disorders and injury related motor disorder. To be included in the study participants must be able to stand on the vibration plate ( with or without assistance) and be able to undertake evaluation assessments.

•Participants will be excluded if:1\)They have a fracture within 8 weeks of enrolment, pregnancy and acute thrombosis, muscle or tendon inflammation, renal stones, discopathy or arthritis. 2\) There is a history of clinically significant organic disease or findings on physical examination, which in the opinion of the Investigator would prevent the patient from completing the study. 3\)There is a history of using any of the following medications, regardless of dose, for at least 1 month, within 3 months of enrolment: anabolic agents, glucocorticoids (does not include inhaled glucocorticoids) or growth hormone. Participants will not receive Botulinium toxin injection throughout duration of the study.